Lanzhou Foci Pharmaceutical Co (SZSE:002644) Accounts Payable & Accrued Expense : ¥264.1 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Lanzhou Foci Pharmaceutical Co Accounts Payable & Accrued Expense?

Lanzhou Foci Pharmaceutical Co's quarterly accounts payable & accrued expense declined from Sep. 2024 (¥352.6 Mil) to Dec. 2024 (¥290.7 Mil) and declined from Dec. 2024 (¥290.7 Mil) to Mar. 2025 (¥264.1 Mil).

Lanzhou Foci Pharmaceutical Co's annual accounts payable & accrued expense declined from Dec. 2022 (¥419.4 Mil) to Dec. 2023 (¥390.1 Mil) and declined from Dec. 2023 (¥390.1 Mil) to Dec. 2024 (¥290.7 Mil).

Lanzhou Foci Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Lanzhou Foci Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lanzhou Foci Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Lanzhou Foci Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

378.21

319.75

419.43

390.14

290.68

Lanzhou Foci Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															387.54	360.72	352.61	290.68	264.13

Lanzhou Foci Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Lanzhou Foci Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lanzhou Foci Pharmaceutical Co Ltd (SZSE:002644) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

68 Foci Street ChangGuan Region, Lanzhou, CHN, 730046

Website

http://www.fczy.com

Lanzhou Foci Pharmaceutical Co Ltd is a pharmaceutical company based in China. The company is engaged in the production and sales of Chinese traditional medicine. In addition to manufacturing, the company also conducts research to develop new herbal drugs. Its product portfolio consists of concentrated pills, granules, hard capsules, concentrated decoctions and medicinal wine. The products of the company are exported to more than 27 countries including the United States, Canada, Japan, Australia, Russia, and Ukraine, among others.

Executives

Sun Yu	Directors, executives
Su Wen Bo	Supervisors
An Wen Ting	Securities Affairs Representative

Lanzhou Foci Pharmaceutical Co Headlines

No Headlines